JPH0365326B2 - - Google Patents

Info

Publication number
JPH0365326B2
JPH0365326B2 JP57193572A JP19357282A JPH0365326B2 JP H0365326 B2 JPH0365326 B2 JP H0365326B2 JP 57193572 A JP57193572 A JP 57193572A JP 19357282 A JP19357282 A JP 19357282A JP H0365326 B2 JPH0365326 B2 JP H0365326B2
Authority
JP
Japan
Prior art keywords
hemoglobin
oxygen
agent
cross
reducing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57193572A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58135818A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS58135818A publication Critical patent/JPS58135818A/ja
Publication of JPH0365326B2 publication Critical patent/JPH0365326B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP57193572A 1981-11-11 1982-11-05 貯蔵寿命の長い高酸素輸送能力を有する交叉結合されたヘモグロビン剤の製法 Granted JPS58135818A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3144705.8 1981-11-11
DE3144705A DE3144705C2 (de) 1981-11-11 1981-11-11 Verfahren zur Herstellung eines lagerstabilen, vernetzten Hämoglobinpräparates mit hoher Sauerstoff-Transportkapazität, sowie das nach diesem Verfahren hergestellte Hämoglobinpräparat

Publications (2)

Publication Number Publication Date
JPS58135818A JPS58135818A (ja) 1983-08-12
JPH0365326B2 true JPH0365326B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-10-11

Family

ID=6146080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57193572A Granted JPS58135818A (ja) 1981-11-11 1982-11-05 貯蔵寿命の長い高酸素輸送能力を有する交叉結合されたヘモグロビン剤の製法

Country Status (5)

Country Link
US (1) US4777244A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0078961B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS58135818A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE22803T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE3144705C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529719A (en) * 1983-05-04 1985-07-16 Tye Ross W Modified crosslinked stroma-free tetrameric hemoglobin
DE3320752A1 (de) * 1983-06-09 1984-12-13 Wolfgang Prof. Dr.Dr. 6500 Mainz Barnikol Lumineszierende schichten zur verwendung in vorrichtungen zur bestimmung der sauerstoffkonzentration in gasen und dergleichen durch messung der lumineszensverringerung
GB8328917D0 (en) * 1983-10-28 1983-11-30 Fisons Plc Blood substitute
DE3340592A1 (de) * 1983-11-10 1985-05-23 B. Braun Melsungen Ag, 3508 Melsungen Konjugate makromolekularer verbindungen an haemoglobine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US5281579A (en) * 1984-03-23 1994-01-25 Baxter International Inc. Purified virus-free hemoglobin solutions and method for making same
USRE34271E (en) * 1984-06-27 1993-06-01 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
NL8403425A (nl) * 1984-11-09 1986-06-02 Stichting Gastransport Stromavrije hemoglobine-oplossing, werkwijze voor de bereiding daarvan en toepassing daarvan.
DE3501349A1 (de) * 1985-01-17 1986-07-17 Battelle-Institut E.V., 6000 Frankfurt Blutersatz
DE3525272A1 (de) * 1985-07-16 1987-01-29 Biotest Pharma Gmbh Verfahren zur herstellung vernetzter haemoglobin-praeparate mit enger molekulargewichtsverteilung
US4826811A (en) * 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
FR2600894B1 (fr) * 1986-07-02 1989-01-13 Centre Nat Rech Scient Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications
US5449759A (en) * 1987-05-16 1995-09-12 Somatogen, Inc. Hemoglobins with intersubunit desulfide bonds
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
GB8712240D0 (en) * 1987-05-23 1987-07-01 Fisons Plc Pharmaceutical formulation
US5844090A (en) * 1994-05-09 1998-12-01 Somatogen, Inc. Modified hemoglobin-like compounds
US5545727A (en) * 1989-05-10 1996-08-13 Somatogen, Inc. DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
US6150506A (en) * 1989-05-10 2000-11-21 Baxter Biotech Technology Sarl Modified hemoglobin-like compounds and methods of purifying same
US5599907A (en) * 1989-05-10 1997-02-04 Somatogen, Inc. Production and use of multimeric hemoglobins
US5234903A (en) * 1989-11-22 1993-08-10 Enzon, Inc. Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute
US5439882A (en) * 1989-12-29 1995-08-08 Texas Tech University Health Sciences Center Blood substitute
ES2082971T3 (es) * 1990-03-14 1996-04-01 Univ Toronto Esteres de fosfato de acilo y modificacion de proteinas con los mismos.
US5352773A (en) * 1990-08-06 1994-10-04 Baxter International Inc. Stable hemoglobin based composition and method to store same
AU9067791A (en) * 1990-11-20 1992-06-11 Enzon, Inc. Method of enhancing long-term storage stability of hemoglobin products
EP0559655B1 (en) * 1990-11-29 1995-03-15 The Upjohn Company Imidoester cross-linked hemoglobin compositions
US5250665A (en) * 1991-05-31 1993-10-05 The University Of Toronto Innovations Foundation Specifically β-β cross-linked hemoglobins and method of preparation
EP0611306B1 (en) * 1991-11-08 1998-07-08 Somatogen, Inc. Hemoglobins as drug delivery agents
US5344393A (en) * 1992-02-28 1994-09-06 Alliance Pharmaceutical Corp. Use of synthetic oxygen carriers to facilitate oxygen delivery
US5264555A (en) * 1992-07-14 1993-11-23 Enzon, Inc. Process for hemoglobin extraction and purification
DK145092D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1992-12-03 1992-12-03 Novo Nordisk As
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
DE4418973A1 (de) * 1994-05-31 1995-12-14 Barnikol Wolfgang Verfahren zur Herstellung molekular-einheitlicher hyperpolymerer Hämoglobine
US5929031A (en) * 1995-05-02 1999-07-27 Baxter Biotech Technology Sarl Storage stable hemoglobin solutions
US6359114B1 (en) * 1995-06-07 2002-03-19 Aphton Corp. System for method for the modification and purification of proteins
US5865784A (en) * 1995-06-07 1999-02-02 Alliance Pharmaceutical Corp. Method of hemodilution facilitated by monitoring oxygenation status
US6054427A (en) * 1997-02-28 2000-04-25 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
US5814601A (en) * 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
CA2391226A1 (en) 1999-11-12 2001-05-17 Baxter International, Inc. Reduced side-effect hemoglobin compositions
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449885C3 (de) * 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
DE2714252C2 (de) * 1977-03-31 1983-08-18 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines für die intravenöse Injektion geeigneten Hämoglobinpräparates mit erhöhter Sauerstoffabgabe gegenüber Erythrozyten
DE2617822C3 (de) * 1976-04-23 1981-01-08 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines für die intravenöse Injektion geeigneten Hämoglobinpräparates mit erhöhter Sauerstoffabgabe gegenüber Erythrozyten
JPS52154515A (en) * 1976-04-23 1977-12-22 Biotest Serum Institut Gmbh Hemoglobin preparation strengthening oxygen release property
US4136093A (en) * 1976-04-23 1979-01-23 Biotest-Serum-Institut Gmbh Hemoglobin preparation with increased oxygen release
ES473087A1 (es) * 1977-09-06 1979-04-16 Studiengesellschaft Kohle Mbh Procedimiento para la preparacion de eritrocitos intactos modificados.

Also Published As

Publication number Publication date
DE3144705A1 (de) 1983-05-19
EP0078961A2 (de) 1983-05-18
DE3273731D1 (en) 1986-11-20
EP0078961B1 (de) 1986-10-15
ATE22803T1 (de) 1986-11-15
JPS58135818A (ja) 1983-08-12
EP0078961A3 (en) 1983-07-27
US4777244A (en) 1988-10-11
DE3144705C2 (de) 1983-12-08

Similar Documents

Publication Publication Date Title
JPH0365326B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US4136093A (en) Hemoglobin preparation with increased oxygen release
NL194909C (nl) Werkwijze voor de bereiding van gepolymeriseerd hemoglobine en celvrij vervangingsmiddel voor rode bloedlichaampjes op basis daarvan.
EP0912197B1 (de) Hämoglobin-hydroxyethylstärke-konjugate als sauerstoff-transport-mittel
DE2607706C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US6914127B2 (en) Acellular red blood cell substitute
US20060287222A1 (en) Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
US20080108555A1 (en) Method and Apparatus for Preparing an Acellular Red Blood Cell Substitute
EP1294385B1 (de) Verfahren zur herstellung künstlicher sauerstoffträger aus kovalent vernetzten hämoglobinen mit verbesserten funktionellen eigenschaften durch vernetzung in anwesenheit chemisch nicht reagierender effektoren der sauerstoffaffinität der hämoglobine
RU2361608C1 (ru) Кровезаменитель с функцией переноса кислорода, фармацевтическая композиция (варианты)
IL87708A (en) Hemoglobin-based blood substitute possessing a colloid oncotic pressure substantially similar to human blood and method for the preparation thereof
ES2395894T3 (es) Hemoglobinas de mamífero compatibles con plasma sanguíneo, reticuladas y conjugadas con poli(óxidos de alquileno) como portadores de oxígeno médicos artificiales, su preparación y su uso
DE69026513T2 (de) Polyhämoglobin durch purinderivate und glutathion stabilisiert
RU2072853C1 (ru) Способ получения искусственного переносчика кислорода
DE69130483T2 (de) Verbesserter blutersatz
JPS6133805B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR20000005058A (ko) 무세포성 적혈구 대체물을 제조하기 위한 방법및 장치
NZ617344B2 (en) Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with high temperature short time heat treatment apparatus